Carrie L. Bourdow, Director at Nabriva Therapeutics plc (NBRV), sold 8,540 shares at $0.17 ($1K) on 2022-08-01, disclosed to the SEC on 2022-08-03.
Open-market sale of $1k NBRV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TRVN | BUY | 2016-11-10 | $17K | — | Filing → |